During the past decade, Azienda Ospedaliera Universitaria Careggi - Unità funzionale di Ematologia conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Azienda Ospedaliera Universitaria Careggi - Unità funzionale di Ematologia" #1 collaborator was "Janssen-Cilag S.p.A." with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Basilea Pharmaceutica International Ltd" with 1 trials as a collaborator and "Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Azienda Ospedaliera Universitaria Careggi - Unità funzionale di Ematologia" are "Aspergillosis" (1 trials), "Chronic Myelomonocytic Leukemia" (1 trials), "Classical Hodgkin Lymphoma" (1 trials), "DLBCL" (1 trials) and "Follicular Lymphoma" (1 trials). Many other conditions were trialed in "Azienda Ospedaliera Universitaria Careggi - Unità funzionale di Ematologia" in a lesser frequency.

Most popular intervention types in "Azienda Ospedaliera Universitaria Careggi - Unità funzionale di Ematologia" are "Drug" (7 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bortezomib" (1 trials), "Consolidation with ADCT-402 (loncastuximab tesirine) after salvage immunochemotherapy (R-BAC, Rituximab - Bendamustine, Ara-C))" (1 trials), "Daratumumab" (1 trials), "Decitabine" (1 trials) and "Dexamethasone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Azienda Ospedaliera Universitaria Careggi - Unità funzionale di Ematologia" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Azienda Ospedaliera Universitaria Careggi - Unità funzionale di Ematologia". 1 are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Azienda Ospedaliera Universitaria Careggi - Unità funzionale di Ematologia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Azienda Ospedaliera Universitaria Careggi - Unità funzionale di Ematologia, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".